Connect with us

Health

Why GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Is Getting Market Attention?

Published

on

GW Pharmaceuticals PLC- ADR

The medicinal cannabis market in the U.S. is a massive growth opportunity many shareholders are overlooking. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Epidiolex is presently in Phase 3 studies and should anticipate an FDA approval by the close of 2017. It shows massive revenue prospects in being one of the initial medicinal cannabis therapies for epilepsy, among other prospective applications.

The details

Blockbuster medicines are like rocket fuel for pharmaceutical stocks. When a new drug approaches blockbuster designation with $1 billion in yearly sales, two good things commonly follow: record share prices and record revenue. This was lately on display with pharmaceutical industry leader Gilead. In 2012, the company launched a promising medication named Sovaldi intended to cure Hepatitis C.

Sovaldi was a massive hit right away, getting blockbuster designation in its first year. That sent stock prices of Gilead surging for the next 3 years. One of the leading pharma firms in the high-growth cannabis division is approaching closer to the first ever cannabis hit. Its promising new medication is in Phase III FDA testing, with an ultimate decision anticipated by the close of 2017.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

The fresh wave of legalization has resulted in the fastest-booming industry in North America. Arcview, the famous research firm, is anticipating North American legal cannabis sales to jump over 200% in the imminent 4 years to $22.8 billion.

GW Pharmaceuticals is a well-known firm in the up-and-coming medicinal cannabis industry. It is headquartered in Salisbury, and has its first listing on the LSE, but shares are also available to investors in the United States through a secondary listing on the reputed Nasdaq platform. The company’s promising medication is Epidiolex, a drug advanced to cure epilepsy.

It marks a potentially lucrative industry for GW. Anticipations indicate that 5 million people in the United States suffer from epilepsy. In spite of that big number, the epilepsy drug industry is said to be underdeveloped. GW Pharmaceuticals is attempting to close that gap with Epidiolex.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         

TRENDING STORIES

INDUSTRIAL HEMP3 months ago

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...

INDUSTRIAL HEMP3 months ago

Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction

CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...

INDUSTRIAL HEMP3 months ago

Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.

Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....

INDUSTRIAL HEMP3 months ago

Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment

Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...

INDUSTRIAL HEMP3 months ago

OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...

INDUSTRIAL HEMP3 months ago

Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution

Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...

INDUSTRIAL HEMP3 months ago

CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up

CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...

INDUSTRIAL HEMP3 months ago

Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market

Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...

INDUSTRIAL HEMP3 months ago

Sunniva Inc. (OTCMKTS:SNNVF) Secures More Funding For Growth Strategy As Plans Solidify Towards A Tremendous Year

Sunniva Inc. (OTCMKTS:SNNVF) is solidifying its growth strategy in anticipation for exponential growth this year. Notably, the firm acquired a...

INDUSTRIAL HEMP3 months ago

Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the...

Advertisement

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play